Why the study?
Does transdermal glyceryl trinitrate (GTN) patch provide 24-hour anti-anginal activity in patients with angina pectoris?
Does transdermal glyceryl trinitrate (GTN) patch provide 24-hour anti-anginal activity in patients with angina pectoris?
Transdermal glyceryl trinitrate patches are introduced as a convenient option for 24-hour anti-anginal therapy.
Answers are grounded in this paper and cite their sources.
Manufacturer claims alone do not confirm 24-hour efficacy; leaves open whether transdermal GTN achieves sustained anti-anginal activity.
Organic nitrates have long been a mainstay in the treatment of angina pectoris and are also used in heart failure.1 A slow-release glyceryl trinitrate (GTN) skin patch (Transiderm-Nitro - Geigy) is now available for angina. The manufacturer claims that the patches are convenient and acceptable to patients, and produce anti-anginal activity lasting 24 hours after a single application.
No takes yet. Share an insight, caveat, or question.
A 1986 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: